Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-04-15

FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Onesource Specialty Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for ondansetron hydrochloride, a generic antiemetic, with Onesource Specialty Pharma Limited as the sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron hydrochloride (ondansetron hydrochloride)

Snippet

SUPPL AP for ONDANSETRON HYDROCHLORIDE (ONDANSETRON HYDROCHLORIDE)